Cite

HARVARD Citation

    Tomyo, F. et al. (2019). Anti‐interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis. Respirology case reports. 7 (2), p. n/a. [Online]. 
  
Back to record